Company intelligence / Profile preview

Abex Pharmaceutica

Port Elizabeth, Eastern Cape, South Africaabexpharm.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Abex Pharmaceutica commercializes a portfolio of registered prescription medicines and branded consumer health products across South Africa and multiple international markets, with a focus on generic pharmaceuticals and select biosimilars. Clinical results and specific program summaries are not publicly detailed but products are described as clinically proven to international standards.[1][2][3]

Modalities: Small moleculeBiosimilarBiologic
Industry: Biotech

Drug pipeline

6 assets

nebivolol

Commercial

Indications: Cardiovascular

5 more assets in the full pipeline.

Request access →

Partnerships

Edge Pharmaceutical group (for international operations)EXTEDO (regulatory electronic submissions in South Africa)

Beyond the preview

Go deeper on Abex Pharmaceutica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abex Pharmaceutica.

Explore the full profile